Selected Publications

Dr. Seddon has published several research findings about the associations between diet and nutrients and the  impact on risk of AMD. These results have been applied to current  dietary guidelines for people with AMD.

 In a collaboration with AMDF, Dr. Seddon has published these 2 cookbooks, Eat Right for Your Sight, and Feast for the Eyes; which incorporate her research findings into healthy recipes, with the goal of reducing visual loss due to AMD.

 As noted in Dr. Seddon's 2014 Introduction of these books

“ YOU ARE WHAT YOU EAT”

was a book her father had when she was growing up, and now we know how true that is, especially for AMD.

Each type of advanced AMD is generally preceded by earlier stages that are characterized by the formation of drusen between the retinal pigment epithelium (RPE) and Bruch's membrane. The elevation of the RPE layer can be quantified by spectral domain–optical coherence tomography (SD-OCT) devices. Here, we used this feature from Zeiss Cirrus OCT to automatically measure the area and volume of drusen and found associations between these parameters and  genes that are highly associated with advanced AMD. We found that risk variants in the CFH gene and in ARMS2/HTRA1 gene are independently associated with greater size of drusen.

Read more about this research on the IOVS journal (free access).

The American Ophthalmological Society (AOS) Thesis 2019.

We expanded our previous Age-related Macular Degeneration (AMD) prediction models by including 13 genes, (a polygenic risk score or GRS) plus demographic risk factors, and showed for the first time the ability of the model to predict visual acuity outcomes. We also validated the model in a large independent cohort. Identifying high-risk individuals at earlier stages could lead to more precise ways to prevent and treat AMD.

Check out the publication at the American Journal of Ophthalmology.

We evaluated morphologic features of the retina and choroid on optical coherence tomography (OCT) and found that OCT features of the retina and choroid could predict progression to advanced stages of AMD, including retinal hyper-reflective loci, nascent GA, and other inner and outer retina irregularities.

Read more about this research on the Investigative Ophthalmology & Visual Science July 2017.

This article is a good summary of decades of research on AMD, including initial studies on diet, nutrition, smoking, and other modifiable factors, as well as common and rare genetic discoveries in the Seddon Lab, related to AMD onset and progression.

Checkout the publication at the IOVS journal.

We determined the association between genetic variants and transition to advanced AMD, and expanded our predictive model and updated our online application to assist in clinical decision making.

The complement factor H (CFH) R1210C rare variant confers the strongest genetic risk for age-related macular degeneration and earlier age at onset. Here, Dr. Seddon and Dr. Ferrara evaluated macular fundus features and disease staging among people with this rare variant. Photographs were retrospectively reviewed from 2012 to 2014. We found for the first time that the typical phenotype of the CFHR1210C rare variant is extensive drusen accumulation in the macula and throughout the fundus, as well as a high risk for advanced disease.

We discovered more novel genetic variants associated with risk of advanced AMD in genes in the complement immune pathway (CFI, C3, and C9 genes) with high impact on the development of this disease. We also showed the initial functional impact of the C3 rare variant.

Together with our collaborators in Boston, other US and European labs, we discovered a rare, high-penetrance variant in the complement factor H (CFH) gene associated with increased risk of age-related macular degeneration. This finding suggests that loss-of-function alleles at CFH are likely to drive AMD risk and represents one of the first instances in which a common complex disease variant has led to the discovery of a rare penetrant mutation. This rare variant is the strongest genetic risk factor for  macular degeneration to date

The Clinical Age-Related Maculopathy Staging (CARMS) system for age-related maculopathy (ARM), uses a simple grading scale designed for clinical practice and clinical research protocols. It is a 5-level clinical scale, a valid and reliable staging system that can be used in both clinical practice and in clinical research protocols involving patients with all stages of ARM. Dr. Seddon evaluates and grades all ocular records and imaging data using this system.

Dr. Seddon conducted the first prospective study to detect the association between cigarette smoking and incidence of AMD. Her team led the analyses of data from the Nurses' Health Study between 1980-1992 in participants who did not report a diagnosis of cancer or AMD at the beginning of the study. We found that women who smoked 25 or more cigarettes per day had double the risk of AMD compared with women who never smoked. Past smokers also had higher risk.

Dr. Seddon led a team of collaborators to obtain diet data at 5 centers using her food frequency questionnaire, and this was the first study to evaluate the intake of specific nutrients and the risk of advanced AMD. Her analyses found that the carotenoids, lutein and zeaxanthin, primarily obtained from dark green, leafy vegetables like spinach and kale, were most strongly associated with a reduced risk for AMD. This was the first evidence leading to current management of patients with AMD to increase intake of dark green, leafy vegetables, and other food rich in lutein and zeaxanthin

Search for Dr. Seddon's and her team's complete research publications at PubMed.